Cargando…
Connecting Patients to Prescription Assistance Programs: Effects on Emergency Department and Hospital Utilization
BACKGROUND: Manufacturer prescription assistance programs (PAPs) have been developed to provide medications at little or no cost to eligible patients. There are over 200 PAPs available from pharmaceutical companies, and each may have different eligibility requirements and assistance guidelines. A fo...
Autores principales: | Burley, Mason H., Daratha, Kenn B., Tuttle, Katherine, White, John R., Wilson, Michael, Armstrong, Kelly, McPherson, Sterling, Selinger, Samuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398071/ https://www.ncbi.nlm.nih.gov/pubmed/27023691 http://dx.doi.org/10.18553/jmcp.2016.22.4.381 |
Ejemplares similares
-
Medication use, renin–angiotensin system inhibitors, and acute care utilization after hospitalization in patients with chronic kidney disease
por: Neumiller, Joshua J, et al.
Publicado: (2020) -
Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry
por: Tuttle, Katherine R., et al.
Publicado: (2019) -
Patient Activation, Depressive Symptoms, and Self-Rated Health: Care Management Intervention Effects among High-Need, Medically Complex Adults
por: Corbett, Cynthia F., et al.
Publicado: (2021) -
Rationale and design of a multicenter Chronic Kidney Disease (CKD) and at-risk for CKD electronic health records-based registry: CURE-CKD
por: Norris, Keith C., et al.
Publicado: (2019) -
Travel Burden and the Direct Medical Costs of Urologic Surgery
por: Olson, Daniel J., et al.
Publicado: (2016)